Who is involved
Before the recent outbreak of meningitis B in Kent, the availability of the meningitis B vaccine was relatively stable, with the vaccine being part of routine childhood immunisations since 2015. Pharmacies like Boots and Superdrug offered the vaccine privately, but demand was manageable. However, this situation changed dramatically as health officials reported an unprecedented rise in meningitis cases, prompting a surge in public interest and demand for vaccinations.
On March 18, 2026, the UK Health and Security Agency (UKHSA) announced that they were investigating 20 cases of meningitis in Kent, which had tragically resulted in two deaths. This alarming news coincided with a staggering 65-fold increase in demand for the meningitis B vaccine compared to the previous week. As a result, both Boots and Superdrug began to experience significant stock shortages, with Boots implementing a queuing system for customers to access its vaccination service page.
Superdrug responded to the crisis by creating a waiting list for the meningitis B vaccine, highlighting the urgency of the situation. The MenB vaccine, which is available privately for approximately £220 for two doses, has become a crucial resource for those seeking protection against the outbreak. However, the vaccine does not cover all group B strains and does not prevent the carriage of the bacteria, raising concerns about its overall effectiveness.
Health officials have described the rise in meningitis cases as unprecedented, prompting immediate action. Approximately 5,000 students are set to be offered the MenB vaccine in the coming days as part of an effort to curb the outbreak. The MenACWY vaccine, which is offered to teenagers in schools, does not protect against meningitis B, further emphasizing the need for the MenB vaccine.
Experts have weighed in on the situation, noting the rapid increase in demand. Dr. Leyla Hannbeck stated, “Demand for the Meningitis B Vaccination Service is currently high and we’re having a few technical difficulties.” She also pointed out that the localised response to the outbreak risks creating a postcode lottery in access to protection, underscoring the need for a more coordinated public health strategy.
The charity Meningitis Now has called for the MenB vaccine to be available at a fair price on the high street, reflecting concerns about accessibility during this critical time. The organization emphasizes that the vaccine should not only be available to those who can afford the private costs, as this could leave vulnerable populations at risk.
As the situation develops, details remain unconfirmed regarding the exact number of available doses of the MenB vaccine and its effectiveness against the current outbreak strain. The ongoing investigation by the UKHSA and the response from healthcare providers will be crucial in determining the next steps in addressing this public health crisis.
